|
answer text |
<p>Since the publication of the Clinical Advisory Panel’s review of cancer services
at Mount Vernon, the following has taken place:</p><p>Discussions are ongoing with
specialist tertiary cancer providers inside and outside of London who could potentially
take on the management of this service.</p><p>Existing clinical leaders at Mount Vernon
have increased their leadership duties at the hospital alongside their clinical responsibilities.
Recruitment of a full-time clinical director will take place in conjunction with the
new provider once they are appointed.</p><p>A business case to appoint additional
staff to the Acute Oncology service was developed and submitted to NHS England. This
has been approved and recruitment has begun.</p><p>Revised admission criteria and
policy and a revised patient transfer policy have been developed and implemented.
Daily consultant ward rounds are now in place. Regular review of transferred patient
treatment and outcomes is underway and is now reported to NHS England along with other
measures and reviewed jointly by the Trust and NHS England. A proposal for an enhanced
7 day a week consultant model and robust outreach medical Acute Oncology Service provision
has been developed and is being considered this month.</p><p>Work is going on to confirm
the radiotherapy equipment replacement programme for 2020/21 and 2021/22, with options
for capital funding being investigated. ENH and Hillingdon Hospitals are meeting regularly
to review and prioritise backlog maintenance within the envelope of available funding.
Progress is reported monthly to NHS England. Since July there has been a whole area
upgrade of the clock tower area, a project has started on refurbishment of the lifts,
fire compartmentalisation has taken place and a project has started on backlog decoration
including MVCC outpatients. Challenges remain around sourcing capital funding for
backlog maintenance and long-term solutions for the service.</p>
|
|